Insights Into Participating in Studies for Uterine Cancer
Launched by POWER LIFE SCIENCES INC. · Aug 11, 2023
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Insights Into Participating in Studies for Uterine Cancer," aims to better understand the experiences of people with uterine cancer who participate in medical studies. The goal is to gather information about the challenges some individuals face when joining these studies and why some may drop out. By collecting this data, researchers hope to improve future clinical trials and make them more accessible to everyone.
To be eligible for this study, participants must be at least 18 years old, have a diagnosis of uterine cancer, and have not received any previous treatment for this condition. Those with certain mental health issues or who are currently in another research study cannot participate. If you join the trial, you can expect to share your experiences and insights about participating in clinical research, which will ultimately help improve the process for others in the future. It's important to note that this trial is not yet recruiting participants, so you would need to wait until it officially starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- • Diagnosis of uterine cancer
- • No prior treatment for uterine cancer
- Exclusion Criteria:
- • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- • Enrolled in another research study
- • Inability to provide written informed consent
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported